IGHV2OR16-5: A Drug Target / Disease Biomarker (G100129631)
IGHV2OR16-5: A Drug Target / Disease Biomarker
IGHV2OR16-5 is a protein that is expressed in most tissues of the body. It is a key regulator of the immune response and has been identified as a potential drug target in the treatment of various diseases.
The IGHV2OR16-5 protein is a member of the interleukin family, which is a group of cytokines and other immune molecules that play a critical role in the immune response. The IGHV2OR16-5 protein is expressed in most tissues of the body, including the skin, hair, and nails, and has been shown to play a role in the regulation of inflammation, immune cell function, and tissue repair.
One of the key functions of the IGHV2OR16-5 protein is its role in the regulation of T cell development and function. T cells are a critical part of the immune system, responsible for cell-mediated immunity against viruses, bacteria, and other pathogens. The IGHV2OR16-5 protein is involved in the regulation of T cell development and function by promoting the expression of genes that are involved in T cell proliferation, differentiation, and survival.
In addition to its role in T cell development, the IGHV2OR16-5 protein is also involved in the regulation of inflammation. Chronic inflammation can lead to a host of diseases, including heart disease, diabetes, and cancer. The IGHV2OR16-5 protein has been shown to play a role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines and limiting the production of anti-inflammatory cytokines.
The IGHV2OR16-5 protein has also been identified as a potential drug target in the treatment of various diseases. For example, studies have shown that inhibiting the activity of the IGHV2OR16-5 protein has the potential to treat autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In addition, the IGHV2OR16-5 protein has also been shown to be involved in the regulation of cancer progression, and inhibiting its activity has the potential to treat cancer.
Overall, the IGHV2OR16-5 protein is a promising drug target for the treatment of various diseases. Further research is needed to fully understand its functions and potential therapeutic uses.
Protein Name: Immunoglobulin Heavy Variable 2/OR16-5 (non-functional)
More Common Targets
IGHV3-11 | IGHV3-13 | IGHV3-15 | IGHV3-16 | IGHV3-19 | IGHV3-20 | IGHV3-21 | IGHV3-22 | IGHV3-23 | IGHV3-25 | IGHV3-29 | IGHV3-30 | IGHV3-30-2 | IGHV3-32 | IGHV3-33 | IGHV3-33-2 | IGHV3-36 | IGHV3-37 | IGHV3-38 | IGHV3-41 | IGHV3-42 | IGHV3-43 | IGHV3-47 | IGHV3-48 | IGHV3-49 | IGHV3-50 | IGHV3-52 | IGHV3-53 | IGHV3-54 | IGHV3-57 | IGHV3-6 | IGHV3-60 | IGHV3-62 | IGHV3-63 | IGHV3-64 | IGHV3-64D | IGHV3-65 | IGHV3-66 | IGHV3-69-1 | IGHV3-7 | IGHV3-71 | IGHV3-72 | IGHV3-73 | IGHV3-74 | IGHV3-75 | IGHV3-76 | IGHV3-79 | IGHV3-9 | IGHV3OR16-10 | IGHV3OR16-12 | IGHV3OR16-13 | IGHV3OR16-17 | IGHV3OR16-6 | IGHV3OR16-7 | IGHV3OR16-9 | IGHV4-28 | IGHV4-30-2 | IGHV4-31 | IGHV4-34 | IGHV4-39 | IGHV4-4 | IGHV4-55 | IGHV4-59 | IGHV4-61 | IGHV4-80 | IGHV5-10-1 | IGHV5-51 | IGHV5-78 | IGHV6-1 | IGHV7-27 | IGHV7-34-1 | IGHV7-4-1 | IGHV7-40 | IGHV7-56 | IGHV7-81 | IGHV8-51-1 | IGHVII-1-1 | IGHVII-15-1 | IGHVII-20-1 | IGHVII-22-1 | IGHVII-26-2 | IGHVII-28-1 | IGHVII-30-1 | IGHVII-31-1 | IGHVII-33-1 | IGHVII-40-1 | IGHVII-43-1 | IGHVII-44-2 | IGHVII-46-1 | IGHVII-49-1 | IGHVII-51-2 | IGHVII-60-1 | IGHVII-62-1 | IGHVII-65-1 | IGHVII-67-1 | IGHVII-74-1 | IGHVII-78-1 | IGHVIII-11-1 | IGHVIII-13-1 | IGHVIII-16-1
